FTH
Faeth Therapeutics, Inc.
There isn't enough reported data to score FTH yet.
FTH Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
FTH's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
FTH PE Valuation
FTH has no meaningful PE right now: it lost money over the past year.
FTH Forward outlook
There aren't enough analyst estimates for FTH to show an outlook.
FTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$138.87 | -$119.74 |
| Q2 2026 | -$141.70 | -$120.39 |
| Q1 2026 | -$142.77 | -$119.77 |
| Q4 2025 | -$16.72 | +$7.28 |
| Q3 2025 | -$19.13 | +$4.67 |
| Q2 2025 | -$21.31 | +$2.29 |
| Q1 2025 | -$23.00 | +$1.20 |
| Q4 2024 | -$24.00 | +$0.40 |
FTH lost $138.87 per share over the past year, a bigger loss than the year before.
FTH Quarterly Revenue
FTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$13M | -$9.4M |
| Q2 2026 | -$15.7M | -$9.7M |
| Q1 2026 | -$10.7M | -$3.6M |
| Q4 2025 | -$3.9M | +$1.9M |
| Q3 2025 | -$3.6M | +$1.9M |
| Q2 2025 | -$5.9M | -$24K |
| Q1 2025 | -$7.1M | +$559K |
| Q4 2024 | -$5.8M | +$371K |
FTH has burned cash in almost every quarter: −$43M over the past year, against −$22M the year before.
FTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +358% | +20.2M shares |
| 1 year | +1949% | +24.6M shares |
| 3 years | +1926% | +24.6M shares |
| 5 years | +1590% | +24.3M shares |
| Available history | +1662% | +24.4M shares |
FTH has 26M diluted shares, up 1949% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $252,000 |
| Q3 2023 | $2.3M |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
FTH Net Leverage
FTH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
FTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 10.1 | Oversold |
FTH's weekly RSI is 37 (neutral) and its Stochastic is 10 (oversold).
FTH PE vs Healthcare Sector
FTH has no meaningful PE right now: it lost money over the past year.
FTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 50% below |
| 20 week MA | $27.2 | 61% below |
| 50 week MA | $22.8 | 53% below |
| 100 week MA | $15.7 | 32% below |
| 200 week MA | $17.4 | 39% below |
FTH is in a downtrend: it's below all five of its weekly moving averages, and 39% below its 200-week average.
FTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $449.8 | $116.0 | -74% |
| 2022 | $116.0 | $28.6 | -75% |
| 2023 | $28.6 | $13.8 | -52% |
| 2024 | $13.8 | $9.96 | -28% |
| 2025 | $9.96 | $9.00 | -9.6% |
| 2026 YTD | $9.00 | $10.7 | +18% |
FTH has finished every year since 2021 lower, and it's up 18% so far in 2026.